Roberta Zappasodi is an Assistant Professor of Hematology in Medicine in the Division of Hematology and Medical Oncology of the Department of Medicine at the Weill Cornell Medical College (New York, NY) and Visiting Investigator at Memorial Sloan Kettering (MSK, New York, NY). Her research program in cancer immunotherapy involves: 1) the study of the immune microenvironment in the pathogenesis of B-cell lymphomas and in the response of these diseases to immunotherapy; 2) the role of B-cell responses in the anti-tumor activity of immune checkpoint blockade therapy; and 3) the definition of T-cell-mediated suppressive mechanisms as targets and biomarkers of immunotherapy.

The overall goal of her research is to identify biomarkers of immune and anti-tumor activity with immediate clinical application and to improve the understanding of the mechanisms underlying resistance to immunotherapy.

She is a Bridge Fellow in the Parker Institute for Cancer Immunotherapy. Dr. Zappasodi completed her PhD in Tumor Immunology/Immunotherapy at the National Cancer Institute of Milan (Milan, Italy) and was the recipient of a Parker Institute for Cancer Immunotherapy Scholar Award during her post-doctoral training at MSK in the Wolchok/Merghoub group.